Mechanocompatible Polymer‐Extracellular‐Matrix Composites for Vascular Tissue Engineering

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Advanced Healthcare Materials

• Publication date

  2016-07-01

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1002/adhm.201501003PMID 27109033PMCID PMC4979004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enabling non-invasive assessment of an engineered endothelium on ePTFE vascular grafts without increasing oxidative stress.

  2015cited by this paper
• A polymer-extracellular matrix composite with improved thromboresistance and recellularization properties.

  2015cited by this paper
• Reprint of: Extracellular matrix as a biological scaffold material: Structure and function.

  2015cited by this paper
• Engineering biodegradable polyester elastomers with antioxidant properties to attenuate oxidative stress in tissues.

  2014cited by this paper
• The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts.

  2013cited by this paper
• Influence of crosslinking on the stiffness and degradation of dermis-derived hydrogels.

  2013cited by this paper
• Strategies and Techniques to Enhance the In Situ Endothelialization of Small-Diameter Biodegradable Polymeric Vascular Grafts

  2013cited by this paper
• Endothelial cells derived from nuclear reprogramming.

  2012cited by this paper
• Role of Inflammation in the Pathogenesis of Arterial Stiffness

  2012cited by this paper
• Development of a growing rat model for the in vivo assessment of engineered aortic conduits.

  2012cited by this paper
• Allogeneic human tissue-engineered blood vessel.

  2012cited by this paper
• Inflammation in osteoarthritis

  2011cited by this paper
• Tissue-Engineered Vascular Grafts

  2011cited by this paper
• Biomaterials for vascular tissue engineering.

  2010cited by this paper
• Inflammation and the osteogenic regulation of vascular calcification: a review and perspective.

  2010cited by this paper
• ECM-Based Materials in Cardiovascular Applications: Inherent Healing Potential and Augmentation of Native Regenerative Processes

  2009cited by this paper
• Development of aliphatic biodegradable photoluminescent polymers

  2009cited by this paper
• Matrix crosslinking forces tumor progression by enhancing integrin signaling.

  2009cited by this paper
• Extracellular matrix as a biological scaffold material: Structure and function.

  2009cited by this paper
• Immobilization of heparin: approaches and applications.

  2008cited by this paper
• Decellularized, xenogeneic small-diameter arteries: transition from a muscular to an elastic phenotype in vivo.

  2008cited by this paper
• Degradation and Healing Characteristics of Small-Diameter Poly(&egr;-Caprolactone) Vascular Grafts in the Rat Systemic Arterial Circulation

  2008cited by this paper
• Matrix Gla-protein: The calcification inhibitor in need of vitamin K

  2008cited by this paper
• Immune response to biologic scaffold materials.

  2008cited by this paper
• Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

  2007cited by this paper
• The role of platelet adhesion receptor GPIbα far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis

  2006cited by this paper
• Vascular Calcification: Pathobiological Mechanisms and Clinical Implications

  2006cited by this paper
• Modulating Expanded Polytetrafluoroethylene Vascular Graft Host Response via Citric Acid‐Based Biodegradable Elastomers

  2006cited by this paper
• Tissue Engineering of Recellularized Small-Diameter Vascular Grafts

  2005cited by this paper
• Novel Biphasic Elastomeric Scaffold for Small-Diameter Blood Vessel Tissue Engineering

  2005cited by this paper
• Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification.

  2005cited by this paper
• Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a review

  2003cited by this paper
• New Markers of Inflammation and Endothelial Cell Activation: Part I

  2003cited by this paper
• Decellularized native and engineered arterial scaffolds for transplantation.

  2003cited by this paper
• Decellularized Native and Engineered Arterial Scaffolds for Transplantation

  2003cited by this paper
• Role of elastin in pathologic calcification of xenograft heart valves.

  2003cited by this paper
• Isolation and Transplantation of Autologous Circulating Endothelial Cells Into Denuded Vessels and Prosthetic Grafts: Implications for Cell-Based Vascular Therapy

  2003cited by this paper
• A Brief Historical Review of the Waterfall/Cascade of Blood Coagulation

  2003cited by this paper
• Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries.

  2003cited by this paper
• In vivo evaluation of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin).

  2002cited by this paper
• Characterization of porous collagen/hyaluronic acid scaffold modified by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide cross-linking.

  2002cited by this paper
• Development and evaluation of a novel decellularized vascular xenograft.

  2002cited by this paper
• Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy

  2001cited by this paper
• Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo

  2001cited by this paper
• Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering.

  2000cited by this paper
• Tissue Engineering of Pulmonary Heart Valves on Allogenic Acellular Matrix Conduits: In Vivo Restoration of Valve Tissue

  2000cited by this paper
• Molecular mechanisms in intimal hyperplasia

  2000cited by this paper
• Intimal hyperplasia in vascular grafts.

  2000cited by this paper
• Compliance mismatch may promote graft-artery intimal hyperplasia by altering suture-line stresses.

  1997cited by this paper
• Inhibition of vascular smooth muscle cell migration by heparin‐like glycosaminoglycans

  1984cited by this paper
• Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase.

  1982cited by this paper
• A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures.

  1982cited by this paper
• Inhibition of Aortic Calcification by means of Pyrophosphate and Polyphosphates

  1965cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• Biomaterials in tissue repair and regeneration: key insights from extracellular matrix biology

  2025cites this paper
• Microenvironment-activatable nanoagent for real-time NIR-II monitoring and targeted therapy of arterial restenosis.

  2025cites this paper
• Bioengineering Strategies for Treating Neointimal Hyperplasia in Peripheral Vasculature: Innovations and Challenges

  2025cites this paper
• Sulfonated PEDOT-Modified Decellularized Arteries as Electroactive Scaffolds for Vascular Tissue Engineering.

  2025cites this paper
• Advances in medical polyesters for vascular tissue engineering

  2024cites this paper
• Citric Acid: A Nexus Between Cellular Mechanisms and Biomaterial Innovations

  2024cites this paper
• Recent advances in the design and immobilization of heparin for biomedical application: A review.

  2024cites this paper
• Strategies to counteract adverse remodeling of vascular graft: A 3D view of current graft innovations

  2023cites this paper
• Role of Biomaterials in Cardiac Repair and Regeneration: Therapeutic Intervention for Myocardial Infarction.

  2022cites this paper
• Engineering multifunctional bioactive citrate-based biomaterials for tissue engineering

  2022cites this paper
• Long-Term Sustained Drug Delivery via 3D Printed Masks for the Development of a Heparin-Loaded Interlayer in Vascular Tissue Engineering Applications.

  2021cites this paper
• In-vivo assessment of a tissue engineered vascular graft computationally optimized for target vessel compliance.

  2021cites this paper
• Distinct Effects of Heparin and Interleukin‐4 Functionalization on Macrophage Polarization and In Situ Arterial Tissue Regeneration Using Resorbable Supramolecular Vascular Grafts in Rats

  2021cites this paper
• Systematic Review of Tissue-Engineered Vascular Grafts

  2021cites this paper
• Extracellular Matrix for Small-Diameter Vascular Grafts

  2020cites this paper
• Advanced Functional Biomaterials for Stem Cell Delivery in Regenerative Engineering and Medicine

  2019cites this paper
• Nanostructured substrates for multi-cue investigations of single cells

  2018cites this paper
• The regeneration of macro-porous electrospun poly(ɛ-caprolactone) vascular graft during long-term in situ implantation.

  2018cites this paper
• Tissue-engineered Vascular Grafts: Balance of the Four Major Requirements

  2018cites this paper
• Vascular scaffolds with enhanced antioxidant activity inhibit graft calcification.

  2017cites this paper
• Improving in vivo outcomes of decellularized vascular grafts via incorporation of a novel extracellular matrix.

  2017cites this paper
• Materials and surface modification for tissue engineered vascular scaffolds

  2016cites this paper
• Targeting Heparin to Collagen within Extracellular Matrix Significantly Reduces Thrombogenicity and Improves Endothelialization of Decellularized Tissues.

  2016cites this paper